As ATTR-CA develops in the setting of both ATTRwt and ATTRv amyloidoses, which are systemic diseases with differing features, the clinical recognition of ATTR-CA is difficult, as it is distorted by the co-existing conditions and morbidities. The gene discussed is TTR; the disease is amyloidosis.